As of January 23, 2025, Biora Therapeutics (BIOR) has a market cap of $2.531 million USD. According to our data, Biora Therapeutics is ranked No.9164 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $2.53 M |
154.41%
|
Dec 31, 2024 | $0.99 M |
-98.37%
|
Dec 29, 2023 | $61.06 M |
-59.00%
|
Dec 30, 2022 | $0.15 B |
-93.70%
|
Dec 31, 2021 | $2.36 B |
-60.64%
|
Dec 31, 2020 | $6.00 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Market Cap | = | BIOR Stock Price | * | BIOR Shares Outstanding |
= | $0.22 | * | 4.52 M | |
= | $2.53 M |